The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ridiculous spread. Funny how some on social media were predicting the demise here.
Nav stated at 19.2p. Still long way to go. DYOR
being paid now.
Agree. Spread is probbaly putting ppl off buying.
10-15p looks fair value here.
Arden Partners (ARDN) Director name: Mr Jonathan B Keeling Amount sold: 25,000 @ 50.00p Value: £12,500
Steve Wassell, the Chief Operating Officer of stockbroker Arden Partners, purchased 195,000 in the stockbroker through his self-invested personal pension on Thursday. Wassell bought the shares at 43.50p each for a total of £84,825, increasing his stake in the company to 373,743 shares, equal to around 1.5% of the issued share capital. On Monday the company reported a decrease in revenues to £5.6m (2011: £7.4m), halving profit before tax to £0.6m (2011: £1.2m). Basic earnings per share fell to 1.7p (2011: 3.7p), with the firm blaming the declines on the ongoing Eurozone problems.
The average market capitalisation of its clients is now £195m. Performance in the second half of the year will depend on market conditions, which given the situation in Europe dictates a need for some caution, the firm warned. The company intends to return to the dividend list from the interim period.
Arden Partners, an institutional stockbroking company, has revealed that trading during the six months ended April 30th has been better than anticipated with revenues and profitability ahead of budget. Since the year end the company has increased the number of brokerships to 34 and this number is expected to grow in the medium term
Arden is becoming the first port of call for Indian businesses looking to raise cash in London that aren’t quite big enough for bulge-bracket firms. Arden earlier this year came up with a trading update which had analysts scurrying to up forecasts. It should be borne in mind, that as recently as last year they did the opposite after a profits warning. So earnings, and the shares, will be volatile. What’s more, a valuation of 23 times forecast looks fancy enough. A speculative buy, according to the Independent.
News that pre-tax profits at Arden Partners (ARDN) are likely to be "significantly" ahead of current market expectations pushed the stockbroker's shares up 10p to 69p. The company, which provides broking services to, and advises on, a range of corporate finance transactions for small and medium sized companies, said it has seen a strong performance both in its core UK business and Indian franchise in the first six months of the current financial year.
http://investegate.co.uk/Article.aspx?id=201105170700157017G
LONDON (Dow Jones)--Stockbrokers Arden Partners PLC (ARDN.LN) Tuesday reported an "encouraging" first half, with revenue increasing 41% and the pretax loss narrowing slightly, and said it was well placed for growth and profitability from both the U.K. and Indian markets. For the six months ended April 30 Arden posted a pretax loss of GBP240,000 compared with a pretax loss of GBP278,000 in the same period a year earlier. Revenue increased to GBP6.5 million from GBP4.6 million while net assets rose to GBP12.3 million from GBP10.3 million. The company won't be paying an interim dividend. Arden also Tuesday said current Chief Executive Jonathan Keeling will become deputy chairman in due course, focusing on developing the company's Indian franchise. The company said Jeremy Grime has been appointed CEO-designate with immediate effect and will take on the role fully before the end of 2010, subject to regulatory approval. -By Rachael Gormley, Dow Jones Newswires; 44-20-7842-9308; rachael.gormley@dowjones.com (END) Dow Jones Newswires June 22, 2010 02:22 ET (06:22 GMT)